Palisade Bio (PALI) Interest Expenses (2010 - 2026)
Palisade Bio (PALI) reported Interest Expenses of $1000.0 for Q1 2026, little changed year-over-year from $1000.0 in Q1 2025, and down 50.0% on a QoQ basis from $2000.0 in Q4 2025.
Palisade Bio (PALI) has 17 years of Interest Expenses data on file, last reported at $1000.0 in Q1 2026.
- Quarterly Interest Expenses changed 0.0% year-over-year to $1000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10000.0 (down 16.67% YoY) and the FY2025 annual result came in at $10000.0, down 16.67% from the prior year.
- Interest Expenses fell to $1000.0 in Q1 2026 per PALI's latest filing, from $2000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $8000.0 in Q3 2023 and bottomed at $1000.0 in Q1 2022.
- The 5-year median for Interest Expenses is $3000.0 (2022), against an average of $3187.5.
- The widest annual swing landed in 2022, when Interest Expenses tumbled 99.94%; it then surged 100.0% in 2023.
- Tracing PALI's Interest Expenses over 5 years: stood at $3000.0 in 2022, then jumped by 33.33% to $4000.0 in 2023, then dropped by 25.0% to $3000.0 in 2024, then sank by 33.33% to $2000.0 in 2025, then tumbled by 50.0% to $1000.0 in 2026.
- Per Business Quant, the three latest PALI Interest Expenses figures stand at $1000.0 (Q1 2026), $2000.0 (Q4 2025), and $5000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 22,854.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -5.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 61,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -332,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 69.29 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | 1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,000.00 |
| Mar 31, 2026 | 1,000.00 |
| Dec 31, 2025 | 2,000.00 |
| Dec 31, 2025 | 2,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Sep 30, 2023 | 8,000.00 |
| Sep 30, 2023 | 8,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 26,000.00 |
| Sep 30, 2021 | 26,000.00 |
| Jun 30, 2021 | 655,000.00 |
| Jun 30, 2021 | 655,000.00 |
| Mar 31, 2021 | 1.71 Mn |
| Mar 31, 2021 | 1.71 Mn |
| Dec 31, 2020 | 196,000.00 |
| Dec 31, 2020 | 196,000.00 |
| Sep 30, 2020 | 28,000.00 |
| Sep 30, 2020 | 28,000.00 |
| Jun 30, 2020 | 8,421.00 |
| Jun 30, 2020 | 8,421.00 |
| Mar 31, 2020 | 2,579.00 |
| Mar 31, 2020 | 2,579.00 |
| Dec 31, 2019 | 4,483.00 |
| Dec 31, 2019 | 4,483.00 |
| Sep 30, 2019 | 1,913.00 |
| Sep 30, 2019 | 1,913.00 |
| Jun 30, 2019 | 507.00 |
| Jun 30, 2019 | 507.00 |
| Mar 31, 2019 | 2,017.00 |
| Mar 31, 2019 | 2,017.00 |
| Dec 31, 2018 | 3,508.00 |
| Dec 31, 2018 | 3,508.00 |
| Sep 30, 2018 | 1,498.00 |
| Sep 30, 2018 | 1,498.00 |
| Jun 30, 2018 | 772.00 |
| Jun 30, 2018 | 772.00 |
| Mar 31, 2018 | 1,920.00 |
| Mar 31, 2018 | 1,920.00 |
| Dec 31, 2017 | 3,223.00 |
| Dec 31, 2017 | 3,223.00 |
| Sep 30, 2017 | 1,383.00 |
| Sep 30, 2017 | 1,383.00 |
| Jun 30, 2017 | 15,728.00 |
| Jun 30, 2017 | 15,728.00 |
| Mar 31, 2017 | 138,732.00 |
| Mar 31, 2017 | 138,732.00 |
| Dec 31, 2016 | 191,922.00 |
| Dec 31, 2016 | 191,922.00 |
| Sep 30, 2016 | 240,462.00 |
| Sep 30, 2016 | 240,462.00 |
| Jun 30, 2016 | 322,407.00 |
| Jun 30, 2016 | 322,407.00 |
| Mar 31, 2016 | 386,506.00 |
| Mar 31, 2016 | 386,506.00 |
| Dec 31, 2015 | 439,202.00 |
| Dec 31, 2015 | 439,202.00 |
| Sep 30, 2015 | 464,197.00 |
| Sep 30, 2015 | 464,197.00 |
| Jun 30, 2015 | 459,073.00 |
| Jun 30, 2015 | 459,073.00 |
| Mar 31, 2015 | 453,734.00 |
| Mar 31, 2015 | 453,734.00 |
| Dec 31, 2014 | 428,800.00 |
| Dec 31, 2014 | 428,800.00 |
| Sep 30, 2014 | 361,619.00 |
| Sep 30, 2014 | 361,619.00 |
| Jun 30, 2014 | 397,616.00 |
| Jun 30, 2014 | 397,616.00 |
| Mar 31, 2014 | 432,741.00 |
| Mar 31, 2014 | 432,741.00 |
| Dec 31, 2013 | 457,803.00 |
| Dec 31, 2013 | 457,803.00 |
| Sep 30, 2013 | 448,943.00 |
| Sep 30, 2013 | 448,943.00 |
| Jun 30, 2013 | 439,271.00 |
| Jun 30, 2013 | 439,271.00 |
| Mar 31, 2013 | 48,257.00 |
| Mar 31, 2013 | 48,257.00 |
| Dec 31, 2012 | 910.00 |
| Dec 31, 2012 | 910.00 |
| Sep 30, 2012 | 335.00 |
| Sep 30, 2012 | 335.00 |
| Jun 30, 2012 | 601.00 |
| Jun 30, 2012 | 601.00 |
| Mar 31, 2012 | 853.00 |
| Mar 31, 2012 | 853.00 |
| Dec 31, 2011 | 821.00 |
| Dec 31, 2011 | 821.00 |
| Dec 31, 2010 | -1.90 Mn |
| Dec 31, 2010 | -1.90 Mn |
| Sep 30, 2010 | 465.00 |
| Sep 30, 2010 | 465.00 |
| Jun 30, 2010 | 1,462.00 |
| Jun 30, 2010 | 1,462.00 |